SUBSCRIBE
SUBSCRIBE
News   Drug Development

ImClone Systems Incorporated Says Its Cancer Drug Works as Initial Treatment

June 20, 2008 | 
1 min read
CHICAGO — Two biotechnology giants did battle here at the nation’s largest cancer conference over the weekend. And both remained standing.
Clinical research Phase 3
MORE ON THIS TOPIC
Balance, equilibrium, stability and movement concepts. Blue sphere is rolling on a yellow curved path over a blue background, creating a minimalist and abstract composition. 3d render.
Gene editing
FDA bolsters bespoke therapy framework with new draft safety guidelines
April 14, 2026
 · 
2 min read
 · 
Gabrielle Masson
Stand out from the crowd and different creative idea concepts , Longest light ladder glowing and aiming high to goal target among other short ladders on green background with shadows . 3D rendering.
Antibody-drug conjugate (ADC)
BioNTech, DualityBio tout ‘clinically meaningful’ efficacy for ADC in mid-stage endometrial cancer trial
April 13, 2026
 · 
2 min read
 · 
Tristan Manalac
Hand pointing upward with growth arrow. Business success and positive progress.
Lymphoma
Allogene stock sails after CAR T clears residual lymphoma in early data cut
April 13, 2026
 · 
3 min read
 · 
Gabrielle Masson
light bulb shot up through the concrete floor.,Thinking Beyond the Box and Going Beyond Expectations,performance beyond expectations,3d rendering
Pancreatic cancer
Revolution rises 40% as pancreatic cancer drug doubles survival
April 13, 2026
 · 
2 min read
 · 
Annalee Armstrong